• Cue Biopharma (NASDAQ: CUE) is a clinical-stage immunotherapy company that has drawn renewed market attention amid heightened trading activity.
• Palisade Bio (NASDAQ: PALI) has attracted attention as interest in speculative small-cap biotech appears to stir.
• Greenwich LifeSciences (NASDAQ: GLSI) has drawn renewed market interest amid attention on cancer-vaccine research.
• Rafael Holdings (NYSE: RFL) is a US holding company with interests spanning clinical-stage biotechnology assets and real estate.
• Rhinebeck Bancorp (NASDAQ: RBKB) shareholders and depositors approved the conversion plan on June 29.
• High Roller Technologies (NYSE American: ROLR) received National Futures Association registration on June 26, 2026.
• Scilex Holding (NASDAQ: SCLX) signed a term sheet to acquire 837 Bitcoin for $50 million from Datavault AI.
• Strats Trust for Procter & Gamble Securities (NYSE: GJR) completed a distribution to certificate holders.
• Security National Financial Corp (NASDAQ: SNFCA) conducted its Annual Meeting of Stockholders in mid-2026.
• Synergy CHC Corp. (NASDAQ: SNYR) shareholders approved an amendment to increase shares available under its 2024 Equity Incentive Plan to 150,000,000.